Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Vitamin D status was not associated with change in CD4 T-cell count after ART initiation.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Multiple reported designs.

Multiple reported designs

More than one design is explicitly reported; examine the supporting methods.

Meta-analysis unclear · Double-blind reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Participants were prospectively followed at monthly clinic visits for a median of 20.6 months.

Source: Abstract.

This prospective cohort study consisted of randomly selected sample of HIV-infected men and women initiating ART enrolled in a double-blind, randomized controlled trial assessing the effect of daily oral supplements of vitamins B-complex, C, and E at high versus standard levels of the recommended dietary allowance (RDA) on HIV disease progression conducted in Dar es Salaam, Tanzania during 2006 to 2010.

Source: Methods.

This prospective cohort study consisted of randomly selected sample of HIV-infected men and women initiating ART enrolled in a double-blind, randomized controlled trial assessing the effect of daily oral supplements of vitamins B-complex, C, and E at high versus standard levels of the recommended dietary allowance (RDA) on HIV disease progression conducted in Dar es Salaam, Tanzania during 2006 to 2010.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D and HIV Progression among Tanzanian Adults Initiating Antiretroviral Therapy

Multiple reported designs · PLoS ONE · 2012

Original publication title

Vitamin D and HIV Progression among Tanzanian Adults Initiating Antiretroviral Therapy

Christopher R. Sudfeld; Molin Wang; Said Aboud; Edward L. Giovannucci; Ferdinand M. Mugusi; Wafaie W. Fawzi

Sudfeld et al.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Deficient vitamin D levels may lead to increased mortality in individuals receiving ART and this relationship does not appear to be due to impaired CD4 T-cell reconstitution. Randomized controlled trials are needed to determine the safety and efficacy of vitamin D supplementation for individuals receiving ART.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

There is growing evidence of an association between low vitamin D and HIV disease progression; however, no prospective studies have been conducted among adults receiving antiretroviral therapy (ART) in sub-Saharan Africa.

Source: Background

Abstract: What methods does the paper describe?

Serum 25-hydroxyvitamin D (25(OH)D) levels were assessed at ART initiation for a randomly selected cohort of HIV-infected adults enrolled in a trial of multivitamins (not including vitamin D) in Tanzania during 2006 to 2010. Participants were prospectively followed at monthly clinic visits for a median of 20.6 months. CD4 T-cell measurements were obtained every 4 months. Proportional hazard models were utilized for mortality analyses while generalized estimating equations were used for CD4 T-cell counts.

Source: Methods

Abstract: Results

Serum 25(OH)D was measured in 1103 adults 9.2% were classified as vitamin D deficient (<20 ng/ml), 43.6% insufficient (20 to 30 ng/mL), and 47.2% as sufficient (>30 ng/mL). After multivariate adjustment, vitamin D deficiency was significantly associated with increased mortality as compared to vitamin D sufficiency (HR: 2.00; 95% CI: 1.19 to 3.37; p = 0.009), whereas no significant association was found for vitamin D insufficiency (HR: 1.24; 95% CI: 0.87 to 1.78; p = 0.24). No effect modification by ART regimen or change in the associations over time was detected.

Vitamin D status was not associated with change in CD4 T-cell count after ART initiation.

Source: Results

Abstract: Conclusions

Deficient vitamin D levels may lead to increased mortality in individuals receiving ART and this relationship does not appear to be due to impaired CD4 T-cell reconstitution. Randomized controlled trials are needed to determine the safety and efficacy of vitamin D supplementation for individuals receiving ART.

Source: Conclusions
Authors’ abstract

Background

There is growing evidence of an association between low vitamin D and HIV disease progression; however, no prospective studies have been conducted among adults receiving antiretroviral therapy (ART) in sub-Saharan Africa.

Methods

Serum 25-hydroxyvitamin D (25(OH)D) levels were assessed at ART initiation for a randomly selected cohort of HIV-infected adults enrolled in a trial of multivitamins (not including vitamin D) in Tanzania during 2006 to 2010. Participants were prospectively followed at monthly clinic visits for a median of 20.6 months. CD4 T-cell measurements were obtained every 4 months. Proportional hazard models were utilized for mortality analyses while generalized estimating equations were used for CD4 T-cell counts.

Results

Serum 25(OH)D was measured in 1103 adults 9.2% were classified as vitamin D deficient (<20 ng/ml), 43.6% insufficient (20 to 30 ng/mL), and 47.2% as sufficient (>30 ng/mL). After multivariate adjustment, vitamin D deficiency was significantly associated with increased mortality as compared to vitamin D sufficiency (HR: 2.00; 95% CI: 1.19 to 3.37; p = 0.009), whereas no significant association was found for vitamin D insufficiency (HR: 1.24; 95% CI: 0.87 to 1.78; p = 0.24). No effect modification by ART regimen or change in the associations over time was detected.

Vitamin D status was not associated with change in CD4 T-cell count after ART initiation.

Conclusions

Deficient vitamin D levels may lead to increased mortality in individuals receiving ART and this relationship does not appear to be due to impaired CD4 T-cell reconstitution. Randomized controlled trials are needed to determine the safety and efficacy of vitamin D supplementation for individuals receiving ART.

Publication and source details

Original title: Vitamin D and HIV Progression among Tanzanian Adults Initiating Antiretroviral Therapy

Christopher R. Sudfeld; Molin Wang; Said Aboud; Edward L. Giovannucci; Ferdinand M. Mugusi; Wafaie W. Fawzi

PLoS ONE · 2012

* E-mail: csudfeld@hsph.harvard.edu

Conceived and designed the experiments: SA FM WWF. Analyzed the data: CRS MW. Wrote the paper: CRS MW SA ELG FMM WWF. Developed the data analysis plan: CRS MW ELG WWF.

Sudfeld et al.2012https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T09:51:44.781280+00:00

DOI: 10.1371/journal.pone.0040036 · PMC3386915